AtaiBeckley Inc. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
7.18
+0.01 (0.14%)
Jul 28, 2026, 10:54 AM EDT - Market open
AtaiBeckley Employees
AtaiBeckley had 99 employees as of December 31, 2025. The number of employees increased by 45 or 83.33% compared to the previous year.
Employees
99
Change (1Y)
45
Growth (1Y)
83.33%
Revenue / Employee
$35,232
Profits / Employee
-$6,700,990
Market Cap
2.66B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 99 | 45 | 83.33% |
| Dec 31, 2024 | 54 | -29 | -34.94% |
| Dec 31, 2023 | 83 | -50 | -37.59% |
| Dec 31, 2022 | 133 | 46 | 52.87% |
| Dec 31, 2021 | 87 | 52 | 148.57% |
| Mar 31, 2021 | 35 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Beam Therapeutics | 522 |
| Tarsus Pharmaceuticals | 370 |
| Vera Therapeutics | 339 |
| Nurix Therapeutics | 317 |
| uniQure | 221 |
| Immunome | 206 |
| Celldex Therapeutics | 198 |
ATAI News
- 8 days ago - AtaiBeckley downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 8 days ago - AtaiBeckley downgraded to Hold from Buy at Berenberg - TheFly
- 9 days ago - The market for psychedelic drugs to treat mental health conditions gets a big buy signal - CNBC
- 10 days ago - AtaiBeckley downgraded to Hold from Buy at TD Cowen - TheFly
- 11 days ago - Helus Pharma price target lowered to $45 from $48 at Guggenheim - TheFly
- 11 days ago - AtaiBeckley downgraded to Hold from Buy at Jefferies - TheFly
- 11 days ago - AtaiBeckley downgraded to Hold from Buy at JonesResearch - TheFly
- 11 days ago - AtaiBeckley downgraded to Hold from Buy at Canaccord - TheFly